OncoSil Medical Ltd (AU:OSL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OncoSil Medical Ltd has announced a new quotation of 690 million fully paid ordinary securities on the Australian Securities Exchange (ASX), set for November 1, 2024. This move is part of a previously disclosed transaction, potentially impacting the company’s stock performance and attracting attention from investors interested in the medical technology sector.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.